Cargando…

S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS

Detalles Bibliográficos
Autores principales: Inusa, B, Hamdy, M, El-Beshlawy, A, Ebeid, F, Kwiatkowski, J, Kanter, J, Williams, S, Lee, D, Temin, N, Fradette, C, Tricta, F, Elalfy, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812081/
http://dx.doi.org/10.1097/01.HS9.0000821448.70992.5a
_version_ 1784644571820457984
author Inusa, B
Hamdy, M
El-Beshlawy, A
Ebeid, F
Kwiatkowski, J
Kanter, J
Williams, S
Lee, D
Temin, N
Fradette, C
Tricta, F
Elalfy, M
author_facet Inusa, B
Hamdy, M
El-Beshlawy, A
Ebeid, F
Kwiatkowski, J
Kanter, J
Williams, S
Lee, D
Temin, N
Fradette, C
Tricta, F
Elalfy, M
author_sort Inusa, B
collection PubMed
description
format Online
Article
Text
id pubmed-8812081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88120812022-02-18 S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS Inusa, B Hamdy, M El-Beshlawy, A Ebeid, F Kwiatkowski, J Kanter, J Williams, S Lee, D Temin, N Fradette, C Tricta, F Elalfy, M Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8812081/ http://dx.doi.org/10.1097/01.HS9.0000821448.70992.5a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Presentations
Inusa, B
Hamdy, M
El-Beshlawy, A
Ebeid, F
Kwiatkowski, J
Kanter, J
Williams, S
Lee, D
Temin, N
Fradette, C
Tricta, F
Elalfy, M
S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
title S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
title_full S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
title_fullStr S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
title_full_unstemmed S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
title_short S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS
title_sort s120: randomized controlled trial of the efficacy and safety of deferiprone: subgroup analysis of pediatric patients in iron-overloaded patients with sickle cell disease and other anemias
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812081/
http://dx.doi.org/10.1097/01.HS9.0000821448.70992.5a
work_keys_str_mv AT inusab s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT hamdym s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT elbeshlawya s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT ebeidf s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT kwiatkowskij s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT kanterj s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT williamss s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT leed s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT teminn s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT fradettec s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT trictaf s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias
AT elalfym s120randomizedcontrolledtrialoftheefficacyandsafetyofdeferipronesubgroupanalysisofpediatricpatientsinironoverloadedpatientswithsicklecelldiseaseandotheranemias